Show source-provided references
2. A meta-analysis on the diagnostic performance of 18F-FDG and 11C-methionine PET for differentiating brain tumors
10.3174/ajnr.A3718 ↗3. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET
10.1007/s00259-001-0690-4 ↗4. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas
5. Stefano, A., Leal, A., Richiusa, S., Trang, P., Comelli, A., Benfante, V., Cosentino, S., Sabini, M.G., Tuttolomondo, A., and Altieri, R. (2021). Robustness of PET radiomics features: Impact of co-registration with MRI. Appl. Sci., 11.
10.3390/app112110170 ↗6. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
10.1093/neuonc/now058 ↗7. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence
8. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: Is a differential diagnosis possible?
10.3171/jns.2003.98.5.1056 ↗9. 11C-methyl-L-methionine PET measuring parameters for the diagnosis of tumour progression against radiation-induced changes in brain metastases
10.1259/bjr.20210275 ↗10. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases
10.1097/RLU.0000000000000561 ↗11. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: Insight from a PET and MR fusion image study
10.1136/jnnp.2003.028480 ↗12. Surgical target selection in cerebral glioma surgery: Linking methionine (MET) PET image fusion and neuronavigation
10.1055/s-2007-991143 ↗14. 18F-NaF PET/CT of obese patients on a lutetium-yttrium oxyorthosilicate PET/CT system: Patient dosimetry, optimization of injected activity, and acquisition time
10.2967/jnmt.120.258137 ↗15. Optimization of intraventricular radioactive concentration for 13N ammonia PET with time-of-flight scanner: Simplified phantom study with noise equivalent count rate analysis
10.17996/anc.23-00178 ↗16. Japanese Society of Nuculear Medicine (2017). Standard PET Imaging Protocols and Phantom Test Procedures and Criteria: Executive Summary, Japanese Society of Nuclear Medicine. Available online: https://jsnm.org/wp_jsnm/wp-content/themes/theme_jsnm/doc/StandardPETProtocolPhantom20170201.pdf.
18. Image quality and semiquantitative measurements on the Biograph Vision PET/CT system: Initial experiences and comparison with the Biograph mCT
10.2967/jnumed.119.227801 ↗19. From a PMT-based to a SiPM-based PET system: A study to define matched acquisition/reconstruction parameters and NEMA performance of the Biograph Vision 450
10.1186/s40658-020-00323-w ↗20. Image quality and qctivity optimization in oncologic 18F-FDG PET using the digital Biograph Vision PET/CT System
10.2967/jnumed.119.234351 ↗21. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT
10.1007/s12149-021-01588-6 ↗22. Weber, M., Jentzen, W., Hofferber, R., Herrmann, K., Fendler, W.P., Rischpler, C., Umutlu, L., Conti, M., Costa, P.F., and Sraieb, M. (2021). Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision. BMC Cancer, 21.
10.1186/s12885-020-07723-2 ↗23. Evaluation of low-dose whole-body FDG PET with SiPM-based PET/CT Scanner: Visual and semi-quantitative analyses using random sampling from full-dose scan data (in Japanese)
10.6009/jjrt.2023-1365 ↗25. Quantification of the impact of TOF and PSF on PET images using the noise-matching concept: Clinical and phantom study
10.1007/s41365-017-0308-6 ↗26. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters
10.2967/jnumed.112.103861 ↗29. Harmonizing SUVs in multicentre trials when using different generation PET systems: Prospective validation in non-small cell lung cancer patients
10.1007/s00259-013-2391-1 ↗30. Edge artifacts in point spread function-based PET reconstruction in relation to object size and reconstruction parameters
31. The added prognostic value of metabolic tumor size on FDG-PET at first suspected recurrence of glioblastoma multiforme
10.1111/jon.12386 ↗32. The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the Brain Tumor Cooperative Group
10.1200/JCO.1988.6.2.338 ↗33. Maximal tumor diameter in the preoperative tumor magnetic resonance imaging (MRI) T2 image is associated with prognosis of Grade II Glioma
10.1097/MD.0000000000024850 ↗34. Diagnostic and prognostic value of 11C-Methionine PET for nonenhancing gliomas
10.3174/ajnr.A4460 ↗35. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
10.1093/neuonc/noac040 ↗36. Nakajo, K., Uda, T., Kawashima, T., Terakawa, Y., Ishibashi, K., Tsuyuguchi, N., Tanoue, Y., Nagahama, A., Uda, H., and Koh, S. (2022). Maximum 11C-methionine PET uptake as a prognostic imaging biomarker for newly diagnosed and untreated astrocytic glioma. Sci. Rep., 12.
10.1038/s41598-021-04216-5 ↗37. Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: Comparison with an MR-based method in FDG imaging
10.1007/s12149-022-01753-5 ↗38. Arrival time mapping with 15O-gas PET for cerebrovascular steno-occlusive diseases: A comparative study with CT perfusion
10.1186/s13550-025-01209-7 ↗39. Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner
10.1007/s12149-023-01886-1 ↗41. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: Local comparison with stereotactic histopathology
10.1158/1078-0432.CCR-04-0262 ↗42. Prognostic value of metabolic tumor volume on 11C-Methionine PET in predicting progression-free survival in high-grade glioma
10.1007/s13139-015-0362-0 ↗45. JASP Team (2025, October 23). JASP (Version 0.95.4) [Computer Software], Available online: https://jasp-stats.org/.
48. Influence of statistical fluctuation on reproducibility and accuracy of SUVmax and SUVpeak: A phantom study
10.2967/jnmt.115.161745 ↗49. For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time
10.1186/s13550-016-0177-8 ↗50. Fujisawa, M., Haga, Y., Sota, M., Abe, M., Kaga, Y., Inaba, Y., Suzuki, M., Meguro, T., Hosoi, Y., and Chida, K. (2023). Evaluation of lens doses among medical staff involved in nuclear medicine: Current eye radiation exposure among nuclear-medicine staff. Appl. Sci., 13.
10.3390/app13169182 ↗51. Fujisawa, M., Sota, M., Haga, Y., Tanaka, S., Kataoka, N., Kato, T., Kaga, Y., Abe, M., Suzuki, M., and Inaba, Y. (2025). Real-time monitoring of occupational radiation exposure in nuclear medicine technologists: An initial study. Appl. Sci., 15.
10.3390/app152011008 ↗52. ICRP (2015). Radiation dose to patients from radiopharmaceuticals: A compendium of current information related to frequently used substances. ICRP Publ., 44, 7–321.
10.1177/0146645314558019 ↗53. What are useful methods to reduce occupational radiation exposure among radiological medical workers, especially for interventional radiology personnel?
10.1007/s12194-022-00660-8 ↗54. Evaluation of radiation dose to the lens in interventional cardiology physicians before and after dose limit regulation changes
10.1088/1361-6498/ad6f19 ↗55. Physician-received scatter radiation with angiography systems used for interventional radiology: Comparison among many X-ray systems
10.1093/rpd/ncr312 ↗